Today: 10 June 2026
Browse Category

NASDAQ:ISRG 20 January 2026 - 30 May 2026

ISRG slips even as Nasdaq hits highs; traders look ahead

ISRG slips even as Nasdaq hits highs; traders look ahead

Intuitive Surgical shares closed at $424.64 Friday, down 3.1% for the week, while the S&P 500 and Nasdaq Composite hit new highs. The company named Taylor Patton as its new chief commercial officer, effective July 1, after a leadership shuffle. First-quarter revenue rose 23% to $2.77 billion, with strong growth in da Vinci and Ion procedures. Investors remain cautious amid tariff risks and U.S. bariatric procedure declines.
30 May 2026
··
ISRG Slips After Goldman Downgrade

ISRG Slips After Goldman Downgrade

Intuitive Surgical shares fell over 4% Wednesday to $416.43 after Goldman Sachs cut its price target to $558. The stock is down about 26% this year, tracking a broader slump in medical-device names. First-quarter revenue rose 23% to $2.77 billion, but the company warned of tariff risks and increased competition in China. The iShares U.S. Medical Devices ETF dropped 2.5%.
27 May 2026
·
Intuitive Surgical Stock Drops 6%: Why ISRG Hit A Fresh 52-Week Low Today

Intuitive Surgical Stock Drops 6%: Why ISRG Hit A Fresh 52-Week Low Today

Intuitive Surgical shares dropped 6.6% Monday to $417.80, hitting a 12-month low after the FDA classified a recall of its SureForm stapler reloads as the most serious type, citing four injuries and one death. The company reported first-quarter revenue up 23% to $2.77 billion, but warned tariffs and safety issues could affect 2026 results. Johnson & Johnson advanced its rival OTTAVA robot in a key gastric-bypass study.
11 May 2026
·
Intuitive Surgical Stock Rebounds As Da Vinci Robot Demand Gives ISRG Bulls A Fresh Test

Intuitive Surgical Stock Rebounds As Da Vinci Robot Demand Gives ISRG Bulls A Fresh Test

Intuitive Surgical shares climbed to $482.22 on April 24 after the company raised its 2026 growth outlook and reported a 23% jump in first-quarter revenue to $2.77 billion. The firm placed 431 da Vinci systems in the quarter and now expects 2026 procedure growth of 13.5% to 15.5%. U.S. bariatric procedures fell 10%, while China and Japan saw slower growth. Competition from Johnson & Johnson and Medtronic is increasing.
25 April 2026
··
Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical shares fell 0.66% to $504.22 Friday, extending a two-day slide after a 2.78% drop Thursday. EVP Myriam Curet sold 126 shares at $520.02 each under a preset plan, while CEO David Rosa received performance stock units set to vest in 2026 and 2027. The company forecasts 2026 procedure growth of 13%-15% and a 67%-68% non-GAAP gross margin, factoring in a 1.2% tariff hit. Markets reopen Monday.
1 February 2026
ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Intuitive Surgical shares fell 0.7% to $525.09 Tuesday after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The S&P 500 ETF rose 0.5% and QQQ gained 0.9%. TD Cowen initiated coverage with a Buy rating and $660 target, citing potential for expanded hospital adoption. Intuitive forecasts 13–15% da Vinci procedure growth in 2026, with a 1.2% revenue hit from tariffs.
27 January 2026
····
ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

Intuitive Surgical shares rose about 1% after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The company plans a limited U.S. rollout through 2026. The clearance follows last week’s warning of slower global procedure growth, with forecasts now at 13% to 15% for 2026. Investors are weighing the new approval against concerns over hospital budgets and rising competition.
26 January 2026
··
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares closed at $523.99 Friday, down 0.4% after the company forecast da Vinci procedure growth of 13%–15% by 2026 and warned tariffs could pressure margins. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted earnings of $2.53 per share. The company reported over 20 million da Vinci procedures worldwide. FDA cleared new cardiac uses for its da Vinci 5 robot.
25 January 2026
··
Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical shares closed Friday at $523.99, down 0.4%, after the company beat quarterly estimates but projected slower da Vinci procedure growth and flagged higher tariff costs for 2026. The firm reported Q4 revenue of $2.87 billion and installed 532 da Vinci systems. U.S. markets remain closed until Monday. Investors focused on tariffs and hospital demand signals heading into next week.
25 January 2026
··
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
23 January 2026
··
Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
23 January 2026
··
Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares rose 0.4% to $525.81 in after-hours trading Thursday after quarterly earnings beat forecasts. The company reported a 19% revenue increase to $2.87 billion, with da Vinci procedures up 17%. Intuitive projects 13%-15% da Vinci procedure growth in 2026 but warned tariffs could cut margins. Investors remain focused on procedure growth and tariff impacts ahead of Friday’s session.
23 January 2026
···
Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
··
Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical shares rose 0.9% to $528.38 Thursday ahead of fourth-quarter earnings, after a recent slide left the stock 14% below its 52-week high. Investors are focused on growth in da Vinci procedures for 2026 after last week’s cautious outlook. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year over year. Results and management commentary are due after the bell.
22 January 2026
··
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
··
1 2 3

Stock Market Today

  • SoftBank Shares Drop 20% Amid OpenAI Funding Concerns
    June 10, 2026, 6:10 AM EDT. SoftBank shares fell by 20% last week as worries mount over its funding commitments to OpenAI. Investors are concerned the Japanese conglomerate might struggle to meet ambitious internal growth targets tied to AI investments. These doubts have raised questions about SoftBank's financial outlook, reducing confidence in what was once Japan's most valuable firm. The slump reflects broader unease among potential creditors about OpenAI's performance and the risks SoftBank faces in backing the AI pioneer.

Latest articles

Oracle Stock Moves Higher as AI Backlog Draws Focus

Oracle Faces $600 Billion AI Bet as Traders Watch for Volatility

10 June 2026
Oracle shares slid nearly 3% to $205.81 ahead of Wednesday’s earnings, as investors await proof that its $553 billion AI cloud backlog can convert to revenue quickly enough to justify heavy data-center spending, with options pricing signaling an 11% stock swing after results.
DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

DraftKings (DKNG) Moves After Prediction-Market News — Traders Focus on Stock

10 June 2026
DraftKings shares soared 11.34% to $27.59 after revealing a 24% month-over-month jump in annualized consumer volume to $1.3 billion and a 34% rise in total volume traded to $3.1 billion in its Predictions product for May, based on preliminary, unaudited data, outpacing a falling Nasdaq and spotlighting investor focus on the product’s revenue potential and DraftKings’ strategic push.
Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
Go toTop